Tag Archives: Heartlink Limited

Novel Flavonoid Compounds That Significantly Reduce Cancer Cell Growth Are Available For Further Research and Development as Anti-Cancer Therapeutics

AsiaNet 45924 PERTH, Aug 16, 2011/Medianet International-AsiaNet/– Australian based Heartlink Limited is developing proprietary synthetic compounds based on the isoflavone structure that have demonstrated anti-cancer efficacy in both laboratory and animal studies at low dosage levels. Compounds tested to date show low levels of toxicity vs normal mammalian cells. The …

Read More »